Clinical Trial Update: Identification of Sentinel Lymph Nodes With Methylene Blue and Isotope [NA]

View source ↗

Summary

This trial update describes using methylene blue with a radiopharmaceutical isotope to identify sentinel lymph nodes in breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• METHYLENE BLUE (METHYLENE BLUE)
• Technetium-99m radiopharmaceutical (technetium-99m radiopharmaceutical)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Infiltrative Breast Cancer | NA | Status: COMPLETED